Ryanair told to remove ‘misleading’ adverts following thousands of complaints
Britain's advertising watchdog has told Ryanair to remove their 'misleading' travel ads after the body received more than 2,000 complaints from viewers.
Britain’s advertising watchdog has told Ryanair to remove its ‘misleading’ travel campaign after the body received more than 2,000 complaints from viewers.
The airline’s recent TV ads were accompanied by the slogan ‘Jab & Go‘ – in reference to COVID-19 vaccines.
A voiceover on the adverts promised that “vaccines are coming – so book your Easter and summer holidays with Ryanair”, proposing holiday destinations such as Spain, Italy, Portugal and Greece.
But the Advertising Standards Authority (ASA) has denounced the campaign, claiming that “the ads misleadingly provided consumers with a reassurance that being vaccinated against COVID-19 was likely to allow them to go on holiday without restrictions.”
The ASA added: “It’s important that all travel companies take particular care, at a time of significant uncertainty about when lockdown restrictions will end, not to mislead or over exaggerate when it will be possible for people to go on holiday.”
ADVERTISEMENT
Ryanair said it disagreed with the “baseless” ruling, but has pulled the advertisements regardless.
A spokesperson for the airline commented: “The ASA’s ruling flies in the face of the UK’s successful vaccine rollout, however even though this ruling is baseless, Ryanair will comply with it and the Jab & Go adverts will not run again.”
Ryanair’s ‘Jab & Go’ campaign had been part of its mission to increase bookings following an extremely tough year – with the airline recording enormous losses since the beginning of the pandemic.
This week, the firm revealed that traffic was down 88% to ‘1.3 million guests’.
It also reported a Q3 loss of €306m – compared to a Q3 profit of €88m in the previous year.
ADVERTISEMENT
The company’s latest financial statement said that 2021 was set to be the “most challenging year in Ryanair’s 35 year history,” predicting the airline could face “a net loss of between €850m and €950m.”
Strict travel rules have kept hundreds of flights grounded in 2021 – with new rules requiring passengers entering the UK to show proof of a negative COVID test and isolate for 10 days upon arrival.
People visiting or returning from 30 ‘high-risk’ countries must stay in specific accommodation for 10 days.
Restrictions are expected to remain in place for some weeks, with the travel industry looking ahead to Prime Minister Boris Johnson’s roadmap for exiting lockdown – due to be announced on the week of February 22.
Manchester Airport’s grand opening of its multi-million revamp of Terminal 2 has also been delayed until at least April, but the first images of the transport hub appeared online earlier this week.
News
Arrest made after 14-year-old boy found in critical condition on Market Street
Daisy Jackson
An arrest has been made after a teenage boy was found unresponsive on Market Street in Manchester city centre.
Detectives believe that the boy, 14, was approached by seven males who stole a designer jacket from him.
Following the altercation, he went into cardiac arrest and was rushed to hospital in a critical condition.
Thankfully, the teenager is continuing to recover well.
Detectives from Manchester City Centre Criminal Investigation Department confirmed that an 18-year-old male was arrested yesterday, Thursday 20 February.
He has been arrested on suspicion of robbery and remains in police custody.
Detective Inspector Mark Astbury of GMP’s City Centre Criminal Investigation Department, said: “We hope the victim can continue his recovery following what must have been a terrifying ordeal for him.
“Officers are fully investigating all aspects of this shocking incident that has left a man with serious injuries in hospital.
“Our work doesn’t stop here, we are continuing to investigate this incident and information from the public plays an incredibly important role in our investigations and I ask that the community keep talking to us and keep sharing their concerns with us so our teams can act.”
If you have any information, contact GMP 101 or 0161 856 4305 quoting log 2854 of 16/2/25.
Comedy is being prescribed instead of antidepressants as part of UK trials
Emily Sergeant
Trials are currently underway to see if comedy could be an alternative to antidepressants as a way to reduce NHS costs.
UK tech company Craic Health has secured important funding for its ‘comedy on prescription’ project that’s aimed at helping the Government work with the comedy industry, communities, and organisations on comedy-based social prescriptions in the hope that they can solve financial struggles within the NHS.
The groundbreaking scheme uses stand-up shows and workshops to help people who are isolated, lonely, and vulnerable.
Craic believes comedy is an ‘untapped opportunity’ to improve health and wellbeing, and has a goal to make comedy easier to access, so that it can help communities experience its mental health and social benefits.
To achieve this, the company has started trialling Comedy-on-Prescription experiences in the UK – starting in London, with the potential for expansion – which includes things like curated comedy panel game show events and workshops, and general stand-up comedy shows at some of the capital’s world-famous venues.
Comedy is being prescribed instead of antidepressants as part of UK trials / Credit: Wikimedia Commons
“Mental health issues like loneliness, isolation, and stress are more common than ever,” the company explains.
“So much so that it’s projected that by 2030, mental health problems, particularly depression, will be the leading cause of mortality and morbidity globally, [but] in this challenging world, comedy stands out as a universal language that breaks barriers.
“Research shows that comedy and laughter have powerful effects – they bring people together, create positive connections, and make life more enjoyable.”
Craic Health says that social prescribing, of which Comedy-on-Prescription is a part of, is all about inclusivity, which makes it making it suitable for people of all ages, backgrounds, and abilities.
Its focus is on personalised support, tailored to individual needs and preferences.